Qinghai Spring Medicinal Resources Technology Co Ltd Total Assets
Qinghai Spring Medicinal Resources Technology Co Ltd total assets. Based on the latest financial reports, Qinghai Spring Medicinal Resources Technology Co Ltd (600381) holds total assets worth CN¥1.02 Billion CNY (≈ $149.28 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market value of Qinghai Spring Medicinal Resources Techn for the company's overall valuation and market capitalisation.
Total Assets of Qinghai Spring Medicinal Resources Technology Co Ltd (1998–2025)
Total assets of Qinghai Spring Medicinal Resources Technology Co Ltd from 1998 to 2025. This chart illustrates how Qinghai Spring Medicinal Resources Technology Co Ltd's total assets have evolved over time, based on quarterly financial data. See today's stock price for Qinghai Spring Medicinal Resources Techn for real-time trading data and today's change.
Qinghai Spring Medicinal Resources Technology Co Ltd - Asset Composition Analysis
Qinghai Spring Medicinal Resources Technology Co Ltd Total Assets Breakdown (December 2025)
Qinghai Spring Medicinal Resources Technology Co Ltd total assets breakdown as of December 2025. Qinghai Spring Medicinal Resources Technology Co Ltd's total assets of CN¥1.02 Billion consist of 62.4% current assets and 37.6% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 15.9% |
| Accounts Receivable | CN¥51.79 Million | 5.0% |
| Inventory | CN¥159.29 Million | 15.3% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥59.30 Million | 5.7% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (1998–2025)
This chart illustrates how Qinghai Spring Medicinal Resources Technology Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital to net assets of Qinghai Spring Medicinal Resources Techn to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Qinghai Spring Medicinal Resources Technology Co Ltd's current assets represent 62.4% of total assets in 2025, a decrease from 79.7% in 1998.
- Cash Position: Cash and equivalents constituted 15.9% of total assets in 2025, up from 3.1% in 1998.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, an increase from 0.0% in 1998.
- Asset Diversification: The largest asset category is inventory at 15.3% of total assets.
Qinghai Spring Medicinal Resources Technology Co Ltd Competitors by Total Assets
Key competitors of Qinghai Spring Medicinal Resources Technology Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Galderma Group N
SW:GALD
|
Switzerland | CHF12.88 Billion |
|
Enzymatica publ AB
ST:ENZY
|
Sweden | Skr149.24 Million |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥13.98 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.01 Billion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
|
Walvax BioTech
SHE:300142
|
China | CN¥10.50 Billion |
Qinghai Spring Medicinal Resources Technology Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 17.66 | 8.14 | 79.31 |
| Quick Ratio | 13.66 | 5.84 | 46.38 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥596.19 Million | CN¥506.50 Million | CN¥1.09 Billion |
Qinghai Spring Medicinal Resources Technology Co Ltd - Advanced Valuation Insights
This section examines the relationship between Qinghai Spring Medicinal Resources Technology Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.31 |
| Latest Market Cap to Assets Ratio | 0.32 |
| Asset Growth Rate (YoY) | -10.3% |
| Total Assets | CN¥1.04 Billion |
| Market Capitalization | $329.88 Million USD |
Valuation Analysis
Below Book Valuation: The market values Qinghai Spring Medicinal Resources Technology Co Ltd's assets below their book value (0.32x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Qinghai Spring Medicinal Resources Technology Co Ltd's assets decreased by 10.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Qinghai Spring Medicinal Resources Technology Co Ltd (1998–2025)
The table below shows the annual total assets of Qinghai Spring Medicinal Resources Technology Co Ltd from 1998 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.04 Billion ≈ $152.84 Million |
-10.29% |
| 2024-12-31 | CN¥1.16 Billion ≈ $170.37 Million |
-14.35% |
| 2023-12-31 | CN¥1.36 Billion ≈ $198.91 Million |
-12.82% |
| 2022-12-31 | CN¥1.56 Billion ≈ $228.16 Million |
-15.63% |
| 2021-12-31 | CN¥1.85 Billion ≈ $270.44 Million |
-16.23% |
| 2020-12-31 | CN¥2.21 Billion ≈ $322.83 Million |
-8.41% |
| 2019-12-31 | CN¥2.41 Billion ≈ $352.48 Million |
-1.10% |
| 2018-12-31 | CN¥2.44 Billion ≈ $356.39 Million |
+0.08% |
| 2017-12-31 | CN¥2.43 Billion ≈ $356.09 Million |
+10.07% |
| 2016-12-31 | CN¥2.21 Billion ≈ $323.50 Million |
+4.63% |
| 2015-12-31 | CN¥2.11 Billion ≈ $309.20 Million |
+47.22% |
| 2014-12-31 | CN¥1.44 Billion ≈ $210.02 Million |
-3.61% |
| 2013-12-31 | CN¥1.49 Billion ≈ $217.89 Million |
-63.25% |
| 2012-12-31 | CN¥4.05 Billion ≈ $592.88 Million |
+2.94% |
| 2011-12-31 | CN¥3.94 Billion ≈ $575.96 Million |
+378.56% |
| 2010-12-31 | CN¥822.48 Million ≈ $120.35 Million |
+136.69% |
| 2009-12-31 | CN¥347.49 Million ≈ $50.85 Million |
-2.99% |
| 2008-12-31 | CN¥358.21 Million ≈ $52.42 Million |
+3.76% |
| 2007-12-31 | CN¥345.21 Million ≈ $50.52 Million |
-20.42% |
| 2006-12-31 | CN¥433.78 Million ≈ $63.48 Million |
-68.40% |
| 2005-12-31 | CN¥1.37 Billion ≈ $200.90 Million |
-19.88% |
| 2004-12-31 | CN¥1.71 Billion ≈ $250.73 Million |
+45.02% |
| 2003-12-31 | CN¥1.18 Billion ≈ $172.89 Million |
+53.90% |
| 2002-12-31 | CN¥767.69 Million ≈ $112.34 Million |
+28.18% |
| 2001-12-31 | CN¥598.92 Million ≈ $87.64 Million |
+95.91% |
| 2000-12-31 | CN¥305.71 Million ≈ $44.73 Million |
+26.63% |
| 1999-12-31 | CN¥241.42 Million ≈ $35.33 Million |
+13.16% |
| 1998-12-31 | CN¥213.35 Million ≈ $31.22 Million |
-- |
About Qinghai Spring Medicinal Resources Technology Co Ltd
Qinghai Spring Medicinal Resources Technology Co., Ltd. manufactures and sells alcoholic beverages and health products in China. It operates through two segments, Wine and Beverage Fast-Moving Consumer Goods and Big Health. The Wine and Beverage Fast-Moving Consumer Goods segment focuses on the sales of alcoholic beverages, including the Tinghua series wines. The Big Health segment engages in the… Read more